A Science & Innovation Webinar, presented by Lilly.

Alzheimer's disease begins years before symptoms appear and progresses along a continuum. This session reviews the clinical stages of AD and why recognizing each stage matters for patients.

• Describe the stages of the AD continuum.
• Explain how underlying AD pathology accumulates and advances.
• Identify the patient, caregiver, and health system implications of progression across each stage.

A Pre-Approval Information Exchange (PIE) Webinar, presented by Bayer.

Recurrent non-cardioembolic ischemic stroke and TIA are a growing population health concern. This webinar is a discussion for formulary decision makers that addresses the recurrent stroke and TIA landscape and offers a clinical overview of an investigational drug and includes the results from the phase 3 clinical study OCEANIC-STROKE.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

An AMCP LINK Group Webinar.

The 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome is the first guideline written jointly by the heart, cardiology, diabetes, and kidney societies—and it cuts across nearly every silo a health plan is organized around. In this kickoff webinar for AMCP's Metabolic Health LINK, we'll unpack the changes with the greatest impact on managed care pharmacy, including staging, risk calculation, therapy selection by comorbidity, and where obesity medications now sit within benefit design. A payer panel will then work through the real-world coverage, clinical, and operational questions plans are facing as these frameworks take hold. Join us to connect with peers and help shape how managed care responds to the evolving management of metabolic health holistically.

An AMCP Webinar

Whether you're a student pharmacist exploring career possibilities, a resident or fellow planning your next step, a pharmacist considering a career transition, or a managed care pharmacy professional looking to deepen your perspective and share the value of our profession with others, this webinar is for you.

Join AMCP and the Membership Committee for an engaging overview of managed care pharmacy and the vital role it plays in improving patient access to medications, supporting evidence-based care, and helping navigate today's complex healthcare landscape.

A Science & Innovation Webinar, presented by AbbVie Medical Affairs.

The objective of this Pharmacokinetic/Pharmacokinetic (PK/PD) analysis is to evaluate Bruton's Tyrosine Kinase (BTK) occupancy at doses included in the US Prescribing Information (USPI) dose modifications for adverse reactions recommendations.

• Review the dose modification guidance for adverse reactions included in the US Prescribing Information.
• Explain the PK/PD findings showing BTK occupancy at doses included in the USPI dose modifications for adverse reactions.